HealthLynked Corp. (HLYK)
OTCMKTS
· Delayed Price · Currency is USD
0.0193
+0.0013 (7.11%)
Jun 25, 2025, 1:52 PM EDT
HealthLynked Revenue
HealthLynked had revenue of $774.21K in the quarter ending March 31, 2025, a decrease of -22.91%. This brings the company's revenue in the last twelve months to $2.78M, down -44.11% year-over-year. In the year 2024, HealthLynked had annual revenue of $3.01M, down -47.43%.
Revenue (ttm)
2.78M
Revenue Growth
-44.11%
P/S Ratio
1.83
Revenue / Employee
138.92K
Employees
20
Market Cap
5.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.01M | -2.71M | -47.43% |
| Dec 31, 2023 | 5.72M | -135.82K | -2.32% |
| Dec 31, 2022 | 5.86M | -638.93K | -9.83% |
| Dec 31, 2021 | 6.50M | 1.13M | 21.09% |
| Dec 31, 2020 | 5.37M | 1.35M | 33.51% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| American Oncology Network | 1.76B |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
HealthLynked News
- 2 months ago - HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers - GlobeNewsWire
- 5 months ago - HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future - GlobeNewsWire
- 5 months ago - HealthLynked apppoints Jeremy Daniel as CFO - Seeking Alpha
- 5 months ago - HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer - GlobeNewsWire
- 7 months ago - HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus - GlobeNewsWire
- 11 months ago - HealthLynked GAAP EPS of -$0.01, revenue of $0.8M - Seeking Alpha
- 11 months ago - HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services - GlobeNewsWire
- 11 months ago - HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients - GlobeNewsWire